|
Continuing Education
 |
Release date: September 18, 2008
Expiration date: September 18, 2009
|
WEB EXCLUSIVE
> |
|
AHDB is included in the following indexing and database services:
Cumulative Index to Nursing and Allied Health Literature (CINAHL)
EBSCOhost research databases (EBSCO)
Editorial
Writing Research Articles on Benefit Design and Policy
By William E. Fassett, BSPharm, MBA, PhD;
Charles R. Phillips, PharmD, PhD
Readers of American Health & Drug Benefits are invited to
submit research articles relevant to benefit design.
Successful publication of...
FULL ARTICLE
Business
Medication Therapy Management Goes Hi-Tech:
Implementing Automated Software Improves
Pharmacy Efficiency
By Adrienne Giordano, PharmD; Carrie Holden, PharmD;
Cathrine Misquitta, PharmD, BCPS
In 2006, CMS’s ruling went into effect, mandating that all Medicare
Part D prescription benefit sponsors must offer their members…
FULL ARTICLE
Stakeholder Perspective by Scott R. Taylor, RPh, MBA
Cost-Effectiveness of Second-Generation Antihistamines and Montelukast in Relieving Nasal Symptoms of Allergic Rhinitis
By Michael J. Goodman, PhD; Mehul Jhaveri, PharmD;
Kim Saverno, RPh; Kellie Meyer, PharmD;
Brian Nightengale, PhD
The purpose of this study was to compare the cost-effectiveness of prescription agents based on their effectiveness in relieving nasal symptoms...
FULL ARTICLE
Stakeholder Perspective by Michael F. Murphy, MD, PhD
Clinical
Evaluation and Management of Diabetes Mellitus
By Quang Nguyen, DO; Loida Nguyen, PharmD;
James Felicetta, MD
Approximately 24 million Americans are currently diagnosed with diabetes, an increase of 3 million over the past 2 years…
FULL ARTICLE
Stakeholder Perspective by Thomas McCarter, MD, FACP
Regulatory
Cutting Through the Politics: Presidential Candidates’
Healthcare Platforms and Impact on Health Benefits
By Peyton Howell, MHA
Healthcare reform is one of the top issues for the presidential elections this year, and both candidates have proposed a wide range of health policy changes…
FULL ARTICLE
Stakeholder Perspective by Joseph R. Antos, PhD
Generic Drug Trends
Presidential Candidates Strong Supporters of
Greater Access to Generic and Biosimilars
By Dalia Buffery, MA, ABD
At the Generic Pharmaceutical Association (GPhA) recent conference, advisors to Barack Obama and John McCain told GPhA members...
FULL ARTICLE
FDA Watch
New Reporting System for Potential Safety Concerns
of Drugs on the Market
By Mark Senak, JD
In early September, the FDA sent a press release posting the first quarterly report, “Potential Signals of Serious Risks/New Safety Information Identified by the Adverse Event Reporting System”…
FULL ARTICLE
|